quinuclidines has been researched along with Breast Cancer in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (12.00) | 29.6817 |
| 2010's | 22 (88.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, K; Ikejiri, F; Inoue, M; Ito, S; Jo, Y; Kawakami, K; Kumanomido, S; Miyake, T; Okada, T; Okada, Y; Onishi, C; Suzuki, R; Suzumiya, J; Takahashi, F; Takahashi, T | 1 |
| Cardillo, FD; Cognetti, F; Evangelista, S; Fabi, A; Fattoruso, SI; Pacetti, U; Veltri, E | 1 |
| Hatake, K; Ito, Y; Nakayama, Y; Takahashi, S; Tanabe, M | 1 |
| Agustoni, F; Celio, L; Damian, S; De Benedictis, E; De Braud, F; Mariani, P; Ricchini, F | 1 |
| Berger, MJ; Blazer, MA; Crawford, BS; Flynn, JM; Griffith, NL; Layman, RM; Lustberg, MB; Mrozek, E; Phillips, GS; Ramaswamy, B; Shapiro, CL; Wenzell, CM; Wesolowski, R | 1 |
| Abuzenadah, AM; Al-Qahtani, MH; Al-Thubaity, F; Buhmeida, A; Chaudhary, AG; Dallol, A; Gari, MA; Karim, S; Merdad, A; Schulten, HJ | 1 |
| El Ashry, el S; Malki, A | 2 |
| Bianchi, S; Cappelli, S; De Luca Cardillo, C; Detti, B; Fambrini, M; Francolini, G; Furfaro, IF; Livi, L; Mangoni, M; Meacci, F; Meattini, I; Muntoni, C; Nori, J; Orzalesi, L; Scoccianti, S; Scotti, V | 1 |
| Enomoto, T; Katoh, H; Kikuchi, M; Kosaka, Y; Kuranami, M; Minatani, N; Nishimiya, H; Sato, T; Sengoku, N; Tanino, H; Waraya, M; Watanabe, M | 1 |
| Boccia, R; Cooper, W; O'Boyle, E | 1 |
| Aapro, M; Rizzi, G; Rossi, G; Rugo, HS | 1 |
| Burdette-Radoux, S; Dugan, M; Grunberg, SM; Muss, H; Siebel, M; Weisberg, T; Wood, M | 1 |
| Pavesi, L; Sagrada, P; Zambelli, A | 1 |
| Aapro, M; Bachmann, C; Fabi, A; Medici, M; Nolè, F; Roila, F; Roncoroni, S; Steger, G | 1 |
| Chen, H; Chen, L; Huang, WQ; Wang, JG; Wei, HJ | 1 |
| Goyal, A; Gupta, YK; Padhy, BM; Shanmugam, SP | 1 |
| Bergmeier, SC; Malki, A | 1 |
| Buchner, D; Cox, D; Hatoum, HT; Lin, SJ | 1 |
| Hesketh, PJ; Sanz-Altamira, P | 1 |
| Balu, S; Buchner, D; Cox, D; Hatoum, HT; Lin, SJ | 1 |
| Aapro, MS; Bajetta, E; Bonizzoni, E; Celio, L; Perrone, T; Sebastiani, S | 1 |
| Chen, JW; Ren, Y; Tan, ZM; Wang, J; Xu, YJ; Zhu, MM; Zhu, Y | 1 |
| Mashour, GA; Pandit, JJ; Picton, P | 1 |
| Andel, J; Angleitner-Boubenizek, L; Bernhart, M; Busch, K; Gehmacher, O; Hernler, T; Kastner, U; Lanz-Veit, A; Petru, E; Pluschnigg, U; Polachova, J; Rohde, M; Schiller, L; Schramböck, R; Stangl, W; Steger, G; Thödtmann, R; Zabernigg, A | 1 |
2 review(s) available for quinuclidines and Breast Cancer
| Article | Year |
|---|---|
Efficacy of NEPA (netupitant/palonosetron) across multiple cycles of chemotherapy in breast cancer patients: A subanalysis from two phase III trials.
Topics: Adult; Aged; Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dexamethasone; Double-Blind Method; Drug Combinations; Female; Humans; Isoquinolines; Middle Aged; Nausea; Pyridines; Quinuclidines; Treatment Outcome; Vomiting; Young Adult | 2017 |
Palonosetron plus single-dose dexamethasone for the prevention of nausea and vomiting in women receiving anthracycline/cyclophosphamide-containing chemotherapy: meta-analysis of individual patient data examining the effect of age on outcome in two phase I
Topics: Adult; Age Factors; Aged; Anthracyclines; Antiemetics; Antineoplastic Agents, Alkylating; Breast Neoplasms; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dexamethasone; Drug Therapy, Combination; Female; Humans; Isoquinolines; Middle Aged; Multicenter Studies as Topic; Nausea; Palonosetron; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vomiting | 2013 |
11 trial(s) available for quinuclidines and Breast Cancer
| Article | Year |
|---|---|
A prospective study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in malignant lymphoma patients following highly emetogenic chemotherapy.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Isoquinolines; Lymphoma; Male; Middle Aged; Nausea; Palonosetron; Prospective Studies; Quinuclidines; Treatment Outcome; Vomiting | 2018 |
A combination of aprepitant, palonosetron, and dexamethasone prevents emesis associated with anthracycline-containing regimens for patients with breast cancer. A retrospective study.
Topics: Adult; Aged; Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Breast Neoplasms; Dexamethasone; Female; Granisetron; Humans; Isoquinolines; Middle Aged; Morpholines; Palonosetron; Quinuclidines; Retrospective Studies; Treatment Outcome; Vomiting | 2015 |
Is a dexamethasone-sparing strategy capable of preventing acute and delayed emesis caused by combined doxorubicin and paclitaxel for breast cancer? Analysis of a phase II trial.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Constipation; Dexamethasone; Doxorubicin; Female; Headache; Humans; Isoquinolines; Middle Aged; Nausea; Paclitaxel; Palonosetron; Quinuclidines; Serotonin Antagonists; Time Factors; Treatment Outcome; Vomiting; Young Adult | 2013 |
Pilot study on the efficacy of an ondansetron- versus palonosetron-containing antiemetic regimen prior to highly emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Isoquinolines; Middle Aged; Morpholines; Nausea; Ondansetron; Palonosetron; Pilot Projects; Prospective Studies; Quinuclidines; Vomiting | 2013 |
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer.
Topics: Adult; Aged; Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dexamethasone; Female; Humans; Isoquinolines; Middle Aged; Morpholines; Nausea; Palonosetron; Quinuclidines; Treatment Outcome; Vomiting | 2015 |
Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapy.
Topics: Adult; Aged; Anthracyclines; Antiemetics; Antineoplastic Agents; Aprepitant; Breast Neoplasms; Dexamethasone; Female; Humans; Isoquinolines; Japan; Middle Aged; Morpholines; Nausea; Palonosetron; Quinuclidines; Vomiting | 2016 |
Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Isoquinolines; Middle Aged; Nausea; Palonosetron; Quinuclidines; Treatment Outcome; Vomiting | 2016 |
Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Breast Neoplasms; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Palonosetron; Quinuclidines; Time Factors; Vomiting | 2009 |
Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Child; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isoquinolines; Maximum Tolerated Dose; Middle Aged; Nausea; Palonosetron; Placebos; Prognosis; Prospective Studies; Quinuclidines; Serotonin Antagonists; Survival Rate; Vomiting; Young Adult | 2010 |
Aprepitant, dexamethasone, and palonosetron in the prevention of doxorubicin/cyclophosphamide-induced nausea and vomiting.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Isoquinolines; Middle Aged; Morpholines; Nausea; Palonosetron; Pilot Projects; Quinuclidines; Vomiting | 2012 |
Effect of penehyclidine hydrochloride on the incidence of intra-operative awareness in Chinese patients undergoing breast cancer surgery during general anaesthesia.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Breast Neoplasms; China; Cholinergic Antagonists; Double-Blind Method; Female; Humans; Incidence; Intraoperative Awareness; Middle Aged; Prospective Studies; Quinuclidines; Young Adult | 2013 |
12 other study(ies) available for quinuclidines and Breast Cancer
| Article | Year |
|---|---|
Single-dose palonosetron and dose-reduced regimen of dexamethasone in preventing nausea and vomiting by anthracycline-including chemotherapy in patients with early breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Isoquinolines; Middle Aged; Nausea; Neoplasm Staging; Palonosetron; Prognosis; Quinuclidines; Serotonin Antagonists; Vomiting | 2013 |
Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
Topics: Animals; Apoptosis; beta Catenin; Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Cell Proliferation; Female; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Matrix Metalloproteinases; Mitochondria; Neoplasm Invasiveness; Neoplasm Metastasis; Oligonucleotide Array Sequence Analysis; Quinuclidines; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2014 |
In vitro and in vivo efficacy of a novel quinuclidinone derivative against breast cancer.
Topics: Animals; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Immunoenzyme Techniques; In Vitro Techniques; Methylnitrosourea; Mitochondria; Quinuclidines; Rats; Rats, Wistar; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Seizure associated with palonosetron.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Isoquinolines; Palonosetron; Quinuclidines; Seizures; Serotonin Antagonists | 2009 |
SR140333 counteracts NK-1 mediated cell proliferation in human breast cancer cell line T47D.
Topics: Antigens, Ly; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cell Proliferation; Female; Humans; Immunoenzyme Techniques; NK Cell Lectin-Like Receptor Subfamily B; Piperidines; Quinuclidines; Tumor Cells, Cultured | 2010 |
Palonosetron induced anaphylaxis in an adult female.
Topics: Adult; Anaphylaxis; Breast Neoplasms; Female; Humans; Isoquinolines; Nausea; Neoplasm Recurrence, Local; Palonosetron; Quinuclidines; Serotonin Antagonists; Vomiting | 2010 |
Novel quinuclidinone derivative 8a induced apoptosis in human MCF-7 breast cancer cell lines.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Ceramides; Dose-Response Relationship, Radiation; Drug Screening Assays, Antitumor; Female; Flow Cytometry; G1 Phase; Gamma Rays; Humans; Quinuclidines; Signal Transduction; Sphingomyelin Phosphodiesterase | 2011 |
Comparative clinical effectiveness of various 5-HT3 RA antiemetic regimens on chemotherapy-induced nausea and vomiting associated with hospital and emergency department visits in real world practice.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Carboplatin; Cisplatin; Cohort Studies; Cyclophosphamide; Databases, Factual; Female; Follow-Up Studies; Hospitalization; Humans; Isoquinolines; Logistic Models; Lung Neoplasms; Male; Middle Aged; Nausea; Palonosetron; Quinuclidines; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Vomiting | 2012 |
Impact of 5-HT3 receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Carboplatin; Cisplatin; Female; Health Care Surveys; Hospitalization; Humans; Isoquinolines; Logistic Models; Lung Neoplasms; Male; Middle Aged; Nausea; Palonosetron; Quinuclidines; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2012 |
Quinuclidinone derivative 6 induced apoptosis in human breast cancer cells via sphingomyelinase and JNK signaling.
Topics: Apoptosis; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Ceramides; Cyclin B; Enzyme-Linked Immunosorbent Assay; Female; Humans; MAP Kinase Signaling System; Quinuclidines; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sphingomyelin Phosphodiesterase | 2012 |
Penehcyclidine and awareness during anaesthesia: caution with zero numerators.
Topics: Anesthesia, General; Breast Neoplasms; Cholinergic Antagonists; Female; Humans; Intraoperative Awareness; Quinuclidines | 2013 |
Early Austrian multicenter experience with palonosetron as antiemetic treatment for patients undergoing highly or moderately emetogenic chemotherapy.
Topics: Adult; Age Factors; Aged; Antiemetics; Antineoplastic Agents; Austria; Breast Neoplasms; Cancer Care Facilities; Female; Humans; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Practice Guidelines as Topic; Product Surveillance, Postmarketing; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Sex Factors; Surveys and Questionnaires; Time Factors; Vomiting | 2008 |